Haemonetics Corp. HAE

NYS: HAE | ISIN: US4050241003   13/03/2026
59,92 USD (+0,72%)
(+0,72%)   13/03/2026

23 februari 2026 · Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology · Persbericht

20 februari 2026 · Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference · Persbericht

5 februari 2026 · Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website · Persbericht

9 januari 2026 · Haemonetics Acquires Vivasure Medical Limited · Persbericht

8 januari 2026 · Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026 · Persbericht

2 januari 2026 · Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference · Persbericht

6 november 2025 · Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website · Persbericht

9 oktober 2025 · Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025 · Persbericht

7 augustus 2025 · Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website · Persbericht

9 juli 2025 · Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025 · Persbericht

30 mei 2025 · Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference · Persbericht

8 mei 2025 · Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website · Persbericht

31 maart 2025 · Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025 · Persbericht

3 maart 2025 · Haemonetics Announces Executive Leadership Updates · Persbericht

15 augustus 2024 · Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System · Persbericht

8 augustus 2024 · Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website · Persbericht

30 juli 2024 · Haemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure Guidewire · Persbericht

8 juli 2024 · Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024 · Persbericht

18 juni 2024 · Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device · Persbericht

23 mei 2024 · Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes · Persbericht

Mijn selecties